Cablegate: Notification of Suspension of Anti-Dumping Measures On
This record is a partial extract of the original cable. The full text of the original cable is not available.
UNCLAS BRASILIA 000757
SIPDIS
PLS PASS USTR FOR SCRONIN
USDOC FOR 3134/USFCS/OIO/WH/EOLSON
USDOC FOR 4332/ITA/MAC/WH/OLAC/MWARD
STATE FOR WHA/BSC DAVID EDWARDS AND EB/TPP/MTA/MST ANDREW
DILWORTH
E.O. 12958: N/A
TAGS: ETRD ECON BR
SUBJECT: NOTIFICATION OF SUSPENSION OF ANTI-DUMPING MEASURES ON
INSULIN
1. Post received a letter dated March 7, 2005 from the
Department of Trade Defense of the Ministry of Development,
Industry and Foreign Trade, notifying the USG of Brazil's
intention to suspend anti-dumping measures for one year
concerning exports to Brazil of medicines containing insulin
originating from Denmark, France and the U.S. An unofficial
translation of the text of the letter follows in paragraph 2.
Original will be filed at Post.
2. Start Text.
Note no. 499/DECOM/CGAP
Rio de Janeiro, March 7, 2005
Ambassador,
In accordance with article 61, sole paragraph, of Decree
no. 1.602 of 1995, we are notifying the U.S. Embassy that
the Chamber of Foreign Trade (CAMEX), by means of
Resolution no. 4, published in today's Diario Oficial da
Uniao (DOU), decided to suspend for one year antidumping
measures applied to importation of medicines containing
insulin, originating from Denmark, France, and the U.S.A.,
based on art. 60 of Decree no. 1602 of August 23, 1995.
The anti-dumping order had been established through CAMEX
Resolution no. 2 of February 23, 2001.
I am attaching a copy of said Resolution in accordance with
the recommendations of Art. 60 of the cited Decree.
Finally, we request that you notify the U.S. firm ELI LILLY
AND COMPANY, INC. regarding the decision contained in CAMEX
Resolution no. 4 of 2005.
(signed Armando de Mello Meziat)
Director of Department of Trade Defense
End Text.
DANILOVICH